| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Endothelial Growth Factor A | 71 | 2024 | 3480 | 5.100 |
Why?
|
| Retinal Pigment Epithelium | 14 | 2022 | 301 | 3.810 |
Why?
|
| Endothelium, Vascular | 61 | 2017 | 4429 | 3.310 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 19 | 2024 | 544 | 3.090 |
Why?
|
| Neovascularization, Physiologic | 29 | 2014 | 1332 | 2.320 |
Why?
|
| Pericytes | 9 | 2017 | 293 | 2.310 |
Why?
|
| Neovascularization, Pathologic | 40 | 2021 | 2638 | 2.120 |
Why?
|
| Endothelial Cells | 23 | 2024 | 3533 | 1.640 |
Why?
|
| Lymphangiogenesis | 8 | 2022 | 172 | 1.580 |
Why?
|
| Endothelial Growth Factors | 22 | 2003 | 672 | 1.570 |
Why?
|
| Macular Degeneration | 9 | 2022 | 1001 | 1.530 |
Why?
|
| Retina | 30 | 2021 | 2635 | 1.520 |
Why?
|
| Muscle, Smooth, Vascular | 24 | 2017 | 1486 | 1.510 |
Why?
|
| Lymphokines | 20 | 2003 | 926 | 1.490 |
Why?
|
| Retinal Neovascularization | 8 | 2017 | 273 | 1.420 |
Why?
|
| Sialoglycoproteins | 2 | 2020 | 315 | 1.200 |
Why?
|
| Capillaries | 19 | 2014 | 744 | 1.150 |
Why?
|
| Gene Expression Regulation, Developmental | 15 | 2011 | 3602 | 1.120 |
Why?
|
| Cell Communication | 17 | 2008 | 1651 | 1.100 |
Why?
|
| Sialomucins | 4 | 2024 | 18 | 1.090 |
Why?
|
| Blood Vessels | 19 | 2012 | 1112 | 1.080 |
Why?
|
| Transforming Growth Factor beta | 16 | 2011 | 1958 | 0.950 |
Why?
|
| Cattle | 48 | 2016 | 3845 | 0.940 |
Why?
|
| Choroid | 5 | 2011 | 349 | 0.890 |
Why?
|
| Coculture Techniques | 13 | 2016 | 1339 | 0.860 |
Why?
|
| Cells, Cultured | 66 | 2017 | 18940 | 0.840 |
Why?
|
| Fibroblast Growth Factor 2 | 14 | 2011 | 590 | 0.810 |
Why?
|
| Diabetic Retinopathy | 7 | 2017 | 1267 | 0.800 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2022 | 127 | 0.780 |
Why?
|
| Animals | 171 | 2022 | 167768 | 0.780 |
Why?
|
| Eye | 6 | 2013 | 710 | 0.770 |
Why?
|
| Geographic Atrophy | 1 | 2022 | 82 | 0.770 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2011 | 607 | 0.760 |
Why?
|
| Signal Transduction | 33 | 2021 | 23342 | 0.750 |
Why?
|
| Pathology | 1 | 2023 | 270 | 0.720 |
Why?
|
| Microcirculation | 11 | 2014 | 1273 | 0.720 |
Why?
|
| Retinal Vessels | 9 | 2017 | 836 | 0.700 |
Why?
|
| Arteries | 6 | 2012 | 1125 | 0.700 |
Why?
|
| Pathology, Clinical | 1 | 2023 | 375 | 0.680 |
Why?
|
| Lymphatic Vessels | 4 | 2016 | 358 | 0.650 |
Why?
|
| Cell Survival | 13 | 2016 | 5781 | 0.650 |
Why?
|
| RNA, Messenger | 24 | 2017 | 12759 | 0.620 |
Why?
|
| Pigment Epithelium of Eye | 4 | 2006 | 209 | 0.620 |
Why?
|
| Glycocalyx | 1 | 2019 | 94 | 0.610 |
Why?
|
| Lipoproteins, LDL | 2 | 2021 | 640 | 0.590 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2021 | 563 | 0.590 |
Why?
|
| Mice | 71 | 2022 | 81101 | 0.580 |
Why?
|
| Choroidal Neovascularization | 4 | 2017 | 357 | 0.580 |
Why?
|
| Angiogenesis Inhibitors | 7 | 2012 | 2047 | 0.580 |
Why?
|
| Growth Substances | 15 | 2001 | 768 | 0.570 |
Why?
|
| Cell Differentiation | 26 | 2016 | 11471 | 0.570 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 686 | 0.560 |
Why?
|
| Veins | 5 | 2012 | 765 | 0.550 |
Why?
|
| Vascular Endothelial Growth Factors | 21 | 2016 | 747 | 0.550 |
Why?
|
| Receptors, Transforming Growth Factor beta | 4 | 2013 | 301 | 0.540 |
Why?
|
| Fibroblast Growth Factors | 18 | 2011 | 867 | 0.540 |
Why?
|
| Capillary Permeability | 4 | 2016 | 769 | 0.530 |
Why?
|
| Platelet-Derived Growth Factor | 8 | 2008 | 617 | 0.530 |
Why?
|
| Cell Movement | 15 | 2019 | 5201 | 0.520 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2020 | 620 | 0.510 |
Why?
|
| Endothelium | 25 | 1995 | 764 | 0.500 |
Why?
|
| Vision, Ocular | 3 | 2023 | 454 | 0.490 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 13 | 2016 | 666 | 0.480 |
Why?
|
| Pregnancy, Animal | 2 | 2012 | 124 | 0.470 |
Why?
|
| Wnt Proteins | 5 | 2007 | 719 | 0.470 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 13 | 2014 | 4567 | 0.460 |
Why?
|
| Cell Division | 32 | 2004 | 4458 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 26 | 2021 | 22003 | 0.450 |
Why?
|
| Inflammasomes | 2 | 2016 | 527 | 0.450 |
Why?
|
| Stress, Mechanical | 3 | 2013 | 1664 | 0.450 |
Why?
|
| Receptors, Notch | 4 | 2014 | 743 | 0.450 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2013 | 44 | 0.440 |
Why?
|
| Blotting, Western | 18 | 2017 | 5031 | 0.440 |
Why?
|
| Interleukin-1beta | 4 | 2014 | 996 | 0.420 |
Why?
|
| Lymphatic System | 1 | 2014 | 254 | 0.420 |
Why?
|
| Membrane Proteins | 8 | 2020 | 7843 | 0.410 |
Why?
|
| Gene Expression Regulation | 9 | 2017 | 11892 | 0.410 |
Why?
|
| Stem Cells | 6 | 2010 | 3521 | 0.400 |
Why?
|
| Ciliary Body | 1 | 2012 | 166 | 0.400 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2014 | 4485 | 0.390 |
Why?
|
| Cholesterol | 1 | 2021 | 2902 | 0.390 |
Why?
|
| Epithelium | 4 | 2016 | 1605 | 0.380 |
Why?
|
| Cell Proliferation | 16 | 2019 | 10416 | 0.380 |
Why?
|
| Blindness | 1 | 2015 | 582 | 0.370 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1842 | 0.360 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2009 | 203 | 0.360 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 6 | 2021 | 557 | 0.350 |
Why?
|
| Cell Line | 16 | 2019 | 15591 | 0.350 |
Why?
|
| Wnt2 Protein | 3 | 2007 | 28 | 0.350 |
Why?
|
| Inflammation | 7 | 2021 | 10718 | 0.350 |
Why?
|
| Tamoxifen | 1 | 2014 | 963 | 0.340 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2020 | 4342 | 0.340 |
Why?
|
| Angiogenesis Inducing Agents | 7 | 2002 | 278 | 0.330 |
Why?
|
| Prosencephalon | 1 | 2011 | 305 | 0.330 |
Why?
|
| CADASIL | 3 | 2017 | 88 | 0.320 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 234 | 0.320 |
Why?
|
| Kruppel-Like Transcription Factors | 4 | 2013 | 503 | 0.310 |
Why?
|
| rho-Associated Kinases | 1 | 2010 | 280 | 0.310 |
Why?
|
| Retinal Artery | 2 | 2016 | 109 | 0.300 |
Why?
|
| Ependyma | 1 | 2008 | 56 | 0.300 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2016 | 1651 | 0.300 |
Why?
|
| Retinal Diseases | 1 | 2014 | 702 | 0.300 |
Why?
|
| Aorta | 18 | 2006 | 2037 | 0.300 |
Why?
|
| Choroid Plexus | 2 | 2008 | 237 | 0.300 |
Why?
|
| Vitreoretinopathy, Proliferative | 3 | 2017 | 68 | 0.300 |
Why?
|
| Up-Regulation | 8 | 2016 | 4113 | 0.300 |
Why?
|
| Cell Culture Techniques | 3 | 2022 | 1664 | 0.300 |
Why?
|
| Neuropilin-1 | 3 | 2014 | 90 | 0.300 |
Why?
|
| Retinal Ganglion Cells | 2 | 2011 | 806 | 0.300 |
Why?
|
| Endocytosis | 3 | 2024 | 958 | 0.290 |
Why?
|
| Heparin | 14 | 2002 | 1632 | 0.290 |
Why?
|
| Wnt1 Protein | 2 | 2007 | 120 | 0.290 |
Why?
|
| Promoter Regions, Genetic | 9 | 2012 | 5779 | 0.290 |
Why?
|
| Adipose Tissue, Brown | 1 | 2013 | 755 | 0.290 |
Why?
|
| Trachea | 1 | 2013 | 1081 | 0.280 |
Why?
|
| Angiopoietins | 1 | 2007 | 84 | 0.280 |
Why?
|
| Mice, Transgenic | 15 | 2017 | 9518 | 0.280 |
Why?
|
| Reperfusion | 1 | 2008 | 270 | 0.280 |
Why?
|
| Phenotype | 7 | 2021 | 16534 | 0.270 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2008 | 268 | 0.270 |
Why?
|
| Humans | 114 | 2024 | 758406 | 0.270 |
Why?
|
| Protein Isoforms | 9 | 2011 | 1694 | 0.270 |
Why?
|
| Gene Expression | 11 | 2014 | 7583 | 0.270 |
Why?
|
| Frizzled Receptors | 1 | 2006 | 90 | 0.270 |
Why?
|
| Leukocytes | 3 | 2016 | 2025 | 0.270 |
Why?
|
| Mesoderm | 4 | 2004 | 672 | 0.270 |
Why?
|
| Receptors, Growth Factor | 5 | 2002 | 326 | 0.270 |
Why?
|
| Lens, Crystalline | 1 | 2008 | 388 | 0.270 |
Why?
|
| Adipocytes | 1 | 2013 | 1177 | 0.270 |
Why?
|
| Muscle Development | 1 | 2007 | 259 | 0.260 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2007 | 277 | 0.260 |
Why?
|
| Immunohistochemistry | 14 | 2017 | 11070 | 0.260 |
Why?
|
| Culture Media, Conditioned | 6 | 2011 | 522 | 0.260 |
Why?
|
| Macrophages | 5 | 2022 | 5737 | 0.250 |
Why?
|
| Apoptosis | 10 | 2017 | 9468 | 0.250 |
Why?
|
| Hot Temperature | 1 | 2011 | 1434 | 0.240 |
Why?
|
| Vasodilation | 1 | 2009 | 960 | 0.240 |
Why?
|
| Corneal Neovascularization | 4 | 2012 | 185 | 0.240 |
Why?
|
| MicroRNAs | 1 | 2021 | 3783 | 0.240 |
Why?
|
| Neurogenesis | 1 | 2011 | 855 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2017 | 367 | 0.240 |
Why?
|
| beta Catenin | 3 | 2006 | 1043 | 0.230 |
Why?
|
| Embryonic and Fetal Development | 2 | 2004 | 420 | 0.230 |
Why?
|
| Receptors, LDL | 1 | 2006 | 485 | 0.230 |
Why?
|
| Blotting, Northern | 9 | 2014 | 1543 | 0.230 |
Why?
|
| Disease Models, Animal | 15 | 2017 | 18119 | 0.230 |
Why?
|
| Blood-Retinal Barrier | 1 | 2003 | 62 | 0.220 |
Why?
|
| Transcription, Genetic | 7 | 2007 | 7590 | 0.220 |
Why?
|
| Hemodynamics | 2 | 2013 | 4159 | 0.220 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2796 | 0.220 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 7 | 2002 | 1613 | 0.220 |
Why?
|
| Mammary Glands, Animal | 1 | 2005 | 271 | 0.220 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2004 | 246 | 0.220 |
Why?
|
| Phosphorylation | 5 | 2019 | 8297 | 0.210 |
Why?
|
| Morphogenesis | 3 | 2017 | 740 | 0.210 |
Why?
|
| Embryonic Induction | 2 | 2002 | 151 | 0.210 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 2 | 2012 | 8 | 0.210 |
Why?
|
| Eye Proteins | 3 | 2011 | 633 | 0.210 |
Why?
|
| Wet Macular Degeneration | 2 | 2017 | 162 | 0.210 |
Why?
|
| Ophthalmology | 1 | 2009 | 549 | 0.200 |
Why?
|
| Aging | 5 | 2011 | 8650 | 0.200 |
Why?
|
| Macaca fascicularis | 4 | 2021 | 900 | 0.200 |
Why?
|
| Swine | 3 | 2022 | 5892 | 0.200 |
Why?
|
| Growth Inhibitors | 3 | 2007 | 378 | 0.200 |
Why?
|
| Ischemia | 6 | 2007 | 1863 | 0.190 |
Why?
|
| Endostatins | 4 | 2016 | 168 | 0.190 |
Why?
|
| Cell Death | 3 | 2016 | 1668 | 0.190 |
Why?
|
| Enzyme Activation | 4 | 2012 | 3593 | 0.190 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 1022 | 0.190 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2012 | 3801 | 0.190 |
Why?
|
| Embryo, Mammalian | 3 | 2005 | 1674 | 0.180 |
Why?
|
| Immunoenzyme Techniques | 5 | 2010 | 1705 | 0.180 |
Why?
|
| Eicosanoids | 2 | 2013 | 278 | 0.180 |
Why?
|
| Collagen Type I | 1 | 2004 | 616 | 0.180 |
Why?
|
| Adenoviridae | 2 | 2019 | 1084 | 0.180 |
Why?
|
| Zebrafish Proteins | 3 | 2002 | 1006 | 0.180 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2014 | 1634 | 0.180 |
Why?
|
| Wound Healing | 3 | 2007 | 2783 | 0.180 |
Why?
|
| DNA Primers | 6 | 2011 | 2816 | 0.180 |
Why?
|
| Recombinant Proteins | 9 | 2011 | 6520 | 0.170 |
Why?
|
| Financing, Organized | 1 | 2021 | 204 | 0.170 |
Why?
|
| Peripheral Nerves | 2 | 2002 | 475 | 0.170 |
Why?
|
| Hypoxia-Inducible Factor 1 | 3 | 2011 | 192 | 0.170 |
Why?
|
| Membrane Glycoproteins | 4 | 2009 | 3705 | 0.170 |
Why?
|
| Homeostasis | 2 | 2009 | 3301 | 0.170 |
Why?
|
| Hedgehog Proteins | 3 | 2011 | 769 | 0.170 |
Why?
|
| Lysosomes | 3 | 2014 | 919 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 5 | 2017 | 6068 | 0.160 |
Why?
|
| Cell Adhesion | 5 | 2016 | 3090 | 0.160 |
Why?
|
| Ephrins | 2 | 2011 | 28 | 0.160 |
Why?
|
| Neoplasm Metastasis | 4 | 2011 | 4901 | 0.150 |
Why?
|
| Base Sequence | 9 | 2014 | 12436 | 0.150 |
Why?
|
| Culture Techniques | 3 | 2000 | 530 | 0.150 |
Why?
|
| Glycosylation | 2 | 2020 | 1095 | 0.150 |
Why?
|
| Corneal Transplantation | 3 | 2012 | 321 | 0.150 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2021 | 459 | 0.150 |
Why?
|
| Angiopoietin-1 | 3 | 2015 | 122 | 0.150 |
Why?
|
| Blood-Brain Barrier | 1 | 2004 | 1018 | 0.150 |
Why?
|
| RNA, Small Interfering | 6 | 2016 | 3432 | 0.150 |
Why?
|
| History, 20th Century | 3 | 2012 | 2772 | 0.150 |
Why?
|
| Models, Biological | 8 | 2011 | 9460 | 0.150 |
Why?
|
| Face | 1 | 2023 | 1017 | 0.150 |
Why?
|
| Epithelial Cells | 6 | 2021 | 3664 | 0.140 |
Why?
|
| Proteins | 5 | 1999 | 6026 | 0.140 |
Why?
|
| Immunoblotting | 2 | 2016 | 1647 | 0.140 |
Why?
|
| Luciferases | 2 | 2012 | 714 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 10 | 2014 | 6209 | 0.140 |
Why?
|
| Cornea | 4 | 2012 | 1326 | 0.140 |
Why?
|
| Microscopy, Electron | 3 | 2013 | 2557 | 0.140 |
Why?
|
| Lac Operon | 2 | 2008 | 237 | 0.140 |
Why?
|
| DNA, Complementary | 4 | 2009 | 1991 | 0.140 |
Why?
|
| Amino Acid Sequence | 6 | 2020 | 13447 | 0.140 |
Why?
|
| Astrocytes | 1 | 2004 | 1337 | 0.140 |
Why?
|
| Phagocytosis | 1 | 2022 | 1533 | 0.130 |
Why?
|
| Extracellular Matrix | 9 | 2007 | 1723 | 0.130 |
Why?
|
| Nerve Growth Factors | 5 | 2011 | 562 | 0.130 |
Why?
|
| DNA | 6 | 2017 | 7199 | 0.130 |
Why?
|
| Epoxy Compounds | 2 | 2013 | 137 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 4 | 2017 | 2646 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2008 | 695 | 0.130 |
Why?
|
| RNA Editing | 1 | 2017 | 151 | 0.130 |
Why?
|
| Muscle, Skeletal | 3 | 2007 | 4902 | 0.130 |
Why?
|
| Retinopathy of Prematurity | 2 | 2006 | 432 | 0.130 |
Why?
|
| Cell Lineage | 4 | 2007 | 2533 | 0.130 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2016 | 132 | 0.130 |
Why?
|
| Transforming Growth Factors | 3 | 1989 | 75 | 0.120 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 350 | 0.120 |
Why?
|
| Mice, Inbred C3H | 2 | 2008 | 915 | 0.120 |
Why?
|
| Genes, Reporter | 2 | 2012 | 1527 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 3754 | 0.120 |
Why?
|
| Receptor, TIE-2 | 3 | 2013 | 176 | 0.120 |
Why?
|
| Flavanones | 1 | 1994 | 73 | 0.120 |
Why?
|
| Receptor, erbB-2 | 1 | 2005 | 2553 | 0.120 |
Why?
|
| Organ Specificity | 4 | 2010 | 1955 | 0.120 |
Why?
|
| Graves Ophthalmopathy | 1 | 2016 | 133 | 0.110 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 151 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 435 | 0.110 |
Why?
|
| History, 21st Century | 2 | 2012 | 1573 | 0.110 |
Why?
|
| Models, Animal | 2 | 2014 | 2112 | 0.110 |
Why?
|
| Rats | 15 | 2011 | 23679 | 0.110 |
Why?
|
| Cell Count | 6 | 2017 | 1835 | 0.110 |
Why?
|
| Cardiovascular System | 1 | 2001 | 835 | 0.110 |
Why?
|
| Ornithine Decarboxylase | 4 | 1992 | 64 | 0.110 |
Why?
|
| Animals, Newborn | 3 | 2011 | 2672 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1996 | 537 | 0.110 |
Why?
|
| Heart | 3 | 2022 | 4382 | 0.110 |
Why?
|
| Liver Regeneration | 1 | 2014 | 213 | 0.100 |
Why?
|
| Arachidonic Acid | 1 | 1994 | 427 | 0.100 |
Why?
|
| Thrombospondin 1 | 2 | 2011 | 257 | 0.100 |
Why?
|
| Oligodendroglia | 1 | 1996 | 536 | 0.100 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2012 | 49 | 0.100 |
Why?
|
| Antigens, Differentiation | 3 | 2007 | 911 | 0.100 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 2221 | 0.100 |
Why?
|
| Eye Diseases | 2 | 2017 | 651 | 0.100 |
Why?
|
| Mice, Knockout | 7 | 2017 | 14354 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 788 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2005 | 8506 | 0.100 |
Why?
|
| Tropoelastin | 1 | 2011 | 28 | 0.100 |
Why?
|
| Bruch Membrane | 1 | 2011 | 65 | 0.100 |
Why?
|
| Rabbits | 7 | 2017 | 4772 | 0.100 |
Why?
|
| Lasers, Semiconductor | 1 | 2011 | 41 | 0.100 |
Why?
|
| Antibodies | 2 | 2017 | 2420 | 0.100 |
Why?
|
| Muscles | 2 | 1994 | 1579 | 0.100 |
Why?
|
| Elastic Tissue | 1 | 2011 | 65 | 0.100 |
Why?
|
| Muscular Dystrophies | 1 | 1994 | 389 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 1171 | 0.100 |
Why?
|
| Vitreous Body | 7 | 2017 | 399 | 0.100 |
Why?
|
| Quinoxalines | 1 | 2013 | 297 | 0.100 |
Why?
|
| Neuropilins | 1 | 2011 | 12 | 0.090 |
Why?
|
| Caspases | 1 | 2014 | 876 | 0.090 |
Why?
|
| Epidermis | 1 | 2014 | 528 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 2012 | 2980 | 0.090 |
Why?
|
| Caspase 3 | 1 | 2013 | 728 | 0.090 |
Why?
|
| Neoplasms | 9 | 2014 | 22032 | 0.090 |
Why?
|
| Smad Proteins | 1 | 2011 | 156 | 0.090 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 206 | 0.090 |
Why?
|
| Mouth Neoplasms | 1 | 2016 | 593 | 0.090 |
Why?
|
| Pregnancy | 6 | 2012 | 29742 | 0.090 |
Why?
|
| Homeodomain Proteins | 2 | 2011 | 2413 | 0.090 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 262 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 2 | 2009 | 119 | 0.090 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 1759 | 0.090 |
Why?
|
| Semaphorins | 1 | 2011 | 96 | 0.090 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 1462 | 0.090 |
Why?
|
| Membrane Transport Proteins | 4 | 2012 | 1034 | 0.090 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2011 | 102 | 0.090 |
Why?
|
| Intracellular Space | 1 | 2011 | 197 | 0.090 |
Why?
|
| Iris | 3 | 1996 | 231 | 0.090 |
Why?
|
| Binding Sites | 3 | 2012 | 6036 | 0.090 |
Why?
|
| Fibroblasts | 6 | 2005 | 4087 | 0.090 |
Why?
|
| Blood-Aqueous Barrier | 1 | 2009 | 7 | 0.090 |
Why?
|
| Retinal Degeneration | 1 | 2014 | 412 | 0.090 |
Why?
|
| Microvessels | 1 | 2014 | 572 | 0.090 |
Why?
|
| Neurites | 2 | 2011 | 390 | 0.090 |
Why?
|
| Serpins | 1 | 2011 | 247 | 0.090 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2012 | 259 | 0.090 |
Why?
|
| Hyaluronic Acid | 2 | 1991 | 482 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 2443 | 0.080 |
Why?
|
| In Situ Hybridization | 4 | 2014 | 1900 | 0.080 |
Why?
|
| Adrenal Cortex | 4 | 1993 | 134 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2012 | 316 | 0.080 |
Why?
|
| Alternative Splicing | 5 | 2002 | 1090 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 4023 | 0.080 |
Why?
|
| Skin Neoplasms | 3 | 2016 | 5797 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 1992 | 593 | 0.080 |
Why?
|
| Collagen | 6 | 2002 | 2635 | 0.080 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 926 | 0.080 |
Why?
|
| Glycoproteins | 5 | 2012 | 2205 | 0.080 |
Why?
|
| Mesenteric Veins | 1 | 2009 | 85 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2008 | 43 | 0.080 |
Why?
|
| Actins | 4 | 2015 | 2049 | 0.080 |
Why?
|
| Molecular Sequence Data | 7 | 2014 | 17617 | 0.080 |
Why?
|
| Male | 30 | 2021 | 358747 | 0.080 |
Why?
|
| Plant Lectins | 1 | 1988 | 103 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2008 | 69 | 0.080 |
Why?
|
| Cell Polarity | 1 | 2012 | 638 | 0.080 |
Why?
|
| Mutation | 3 | 2021 | 29915 | 0.080 |
Why?
|
| Acetylcysteine | 1 | 2009 | 261 | 0.080 |
Why?
|
| Retinal Neurons | 1 | 2008 | 66 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2011 | 746 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2004 | 1969 | 0.080 |
Why?
|
| Carboxy-Lyases | 2 | 1978 | 85 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 609 | 0.070 |
Why?
|
| Gene Targeting | 3 | 2017 | 837 | 0.070 |
Why?
|
| Trans-Activators | 3 | 2003 | 2860 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2008 | 169 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 426 | 0.070 |
Why?
|
| Solubility | 1 | 2009 | 1088 | 0.070 |
Why?
|
| Epidermal Growth Factor | 3 | 2005 | 695 | 0.070 |
Why?
|
| Electroretinography | 1 | 2009 | 517 | 0.070 |
Why?
|
| Aquaporins | 1 | 2008 | 174 | 0.070 |
Why?
|
| Angiogenic Proteins | 1 | 2008 | 101 | 0.070 |
Why?
|
| Cell Separation | 3 | 2015 | 1720 | 0.070 |
Why?
|
| Axons | 4 | 1990 | 1673 | 0.070 |
Why?
|
| Myocardium | 3 | 1999 | 4690 | 0.070 |
Why?
|
| Cyclohexanes | 1 | 2008 | 152 | 0.070 |
Why?
|
| Amides | 1 | 2010 | 447 | 0.070 |
Why?
|
| MyoD Protein | 1 | 2007 | 142 | 0.070 |
Why?
|
| Imidazoles | 1 | 2013 | 1179 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 1992 | 802 | 0.070 |
Why?
|
| Teratoma | 2 | 1992 | 403 | 0.070 |
Why?
|
| Cilia | 1 | 2011 | 493 | 0.070 |
Why?
|
| Collateral Circulation | 2 | 1987 | 292 | 0.070 |
Why?
|
| E-Selectin | 1 | 2009 | 576 | 0.070 |
Why?
|
| Sesquiterpenes | 1 | 2008 | 176 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2016 | 2564 | 0.070 |
Why?
|
| Intestines | 1 | 2016 | 1906 | 0.070 |
Why?
|
| P-Selectin | 1 | 2009 | 597 | 0.070 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2009 | 691 | 0.070 |
Why?
|
| Glycosaminoglycans | 2 | 1988 | 605 | 0.070 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 1228 | 0.070 |
Why?
|
| RNA | 1 | 2016 | 2716 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2006 | 138 | 0.070 |
Why?
|
| Leydig Cells | 1 | 2006 | 55 | 0.070 |
Why?
|
| Angiopoietin-2 | 1 | 2007 | 172 | 0.070 |
Why?
|
| Receptors, Cell Surface | 2 | 2006 | 2825 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2007 | 10748 | 0.070 |
Why?
|
| Allergy and Immunology | 1 | 2008 | 175 | 0.070 |
Why?
|
| Genomic Imprinting | 1 | 2008 | 330 | 0.070 |
Why?
|
| Body Patterning | 2 | 2002 | 632 | 0.070 |
Why?
|
| Point Mutation | 2 | 2004 | 1593 | 0.060 |
Why?
|
| Venules | 2 | 2002 | 164 | 0.060 |
Why?
|
| Nerve Regeneration | 2 | 1989 | 790 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2850 | 0.060 |
Why?
|
| Tissue Extracts | 3 | 1984 | 140 | 0.060 |
Why?
|
| Ligands | 2 | 2006 | 3258 | 0.060 |
Why?
|
| Nitric Oxide | 2 | 2013 | 2131 | 0.060 |
Why?
|
| Female | 26 | 2017 | 390323 | 0.060 |
Why?
|
| Fibronectins | 3 | 2004 | 722 | 0.060 |
Why?
|
| Leukocyte Count | 1 | 2009 | 1593 | 0.060 |
Why?
|
| Arterioles | 2 | 2002 | 250 | 0.060 |
Why?
|
| Muscle Cells | 1 | 2006 | 194 | 0.060 |
Why?
|
| Tumor Escape | 1 | 2008 | 370 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2002 | 1342 | 0.060 |
Why?
|
| Blotting, Southern | 2 | 1996 | 777 | 0.060 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 551 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2006 | 574 | 0.060 |
Why?
|
| Fucose | 1 | 2005 | 122 | 0.060 |
Why?
|
| Retinal Vein Occlusion | 2 | 1996 | 149 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2017 | 12075 | 0.060 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2004 | 42 | 0.060 |
Why?
|
| Atrophy | 1 | 2009 | 1627 | 0.060 |
Why?
|
| Salivary Glands | 1 | 2006 | 229 | 0.060 |
Why?
|
| Mitogens | 1 | 1984 | 230 | 0.060 |
Why?
|
| Phenyl Ethers | 1 | 2004 | 61 | 0.060 |
Why?
|
| Caveolins | 1 | 2004 | 101 | 0.060 |
Why?
|
| Regeneration | 1 | 2013 | 1505 | 0.060 |
Why?
|
| Fibrosarcoma | 2 | 2005 | 308 | 0.060 |
Why?
|
| Neuregulin-1 | 1 | 2005 | 135 | 0.060 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2004 | 144 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1477 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2014 | 1055 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1994 | 2825 | 0.060 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2005 | 167 | 0.060 |
Why?
|
| Erythropoiesis | 1 | 2008 | 682 | 0.060 |
Why?
|
| Receptor, erbB-3 | 1 | 2005 | 143 | 0.060 |
Why?
|
| Antigens, Surface | 1 | 1988 | 1607 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2002 | 3796 | 0.060 |
Why?
|
| Cadherins | 1 | 2008 | 898 | 0.060 |
Why?
|
| Models, Cardiovascular | 2 | 2001 | 972 | 0.050 |
Why?
|
| Smad3 Protein | 1 | 2003 | 166 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 2008 | 255 | 0.050 |
Why?
|
| Basement Membrane | 3 | 1990 | 348 | 0.050 |
Why?
|
| Cytosol | 1 | 2006 | 886 | 0.050 |
Why?
|
| Plasmids | 2 | 2008 | 2275 | 0.050 |
Why?
|
| Liver | 3 | 2014 | 7502 | 0.050 |
Why?
|
| Thrombin | 5 | 1995 | 590 | 0.050 |
Why?
|
| Transfection | 3 | 2008 | 5779 | 0.050 |
Why?
|
| Gels | 1 | 2004 | 419 | 0.050 |
Why?
|
| Graft Survival | 2 | 2012 | 3794 | 0.050 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 2002 | 16 | 0.050 |
Why?
|
| Clathrin | 1 | 2024 | 257 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2004 | 256 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2015 | 550 | 0.050 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2004 | 267 | 0.050 |
Why?
|
| Diaphragm | 1 | 2004 | 351 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 2 | 1998 | 900 | 0.050 |
Why?
|
| Integrins | 2 | 1997 | 836 | 0.050 |
Why?
|
| Thalidomide | 1 | 2008 | 884 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 4169 | 0.050 |
Why?
|
| Connexins | 1 | 2004 | 351 | 0.050 |
Why?
|
| Mitochondria | 2 | 2013 | 3584 | 0.050 |
Why?
|
| Retinal Pigments | 1 | 2021 | 83 | 0.050 |
Why?
|
| COS Cells | 2 | 2005 | 1128 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2004 | 316 | 0.050 |
Why?
|
| Podocytes | 1 | 2006 | 402 | 0.050 |
Why?
|
| Dependovirus | 2 | 2017 | 711 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1136 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 651 | 0.050 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2004 | 338 | 0.050 |
Why?
|
| Adult | 11 | 2022 | 219935 | 0.050 |
Why?
|
| Culture Media | 3 | 1989 | 899 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2010 | 2470 | 0.050 |
Why?
|
| Endothelium, Lymphatic | 2 | 2012 | 63 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2005 | 3733 | 0.050 |
Why?
|
| Oxygen | 2 | 2017 | 4191 | 0.050 |
Why?
|
| Protein Binding | 3 | 2012 | 9311 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2017 | 15773 | 0.050 |
Why?
|
| Glucose | 2 | 2017 | 4336 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 1931 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2002 | 276 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1262 | 0.040 |
Why?
|
| Histamine | 3 | 1988 | 497 | 0.040 |
Why?
|
| Calcium | 3 | 1978 | 5721 | 0.040 |
Why?
|
| Hypothalamus | 2 | 1986 | 998 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2004 | 754 | 0.040 |
Why?
|
| Molecular Weight | 4 | 1989 | 2185 | 0.040 |
Why?
|
| Mice, Nude | 3 | 2014 | 3602 | 0.040 |
Why?
|
| Serotonin | 4 | 1988 | 1040 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2013 | 4938 | 0.040 |
Why?
|
| Lectins | 2 | 1994 | 484 | 0.040 |
Why?
|
| Osmotic Pressure | 1 | 1999 | 137 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 3774 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 237 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2007 | 2693 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2012 | 4426 | 0.040 |
Why?
|
| Gestational Age | 2 | 2006 | 3565 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2001 | 728 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2004 | 716 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2006 | 1230 | 0.040 |
Why?
|
| Permeability | 1 | 2001 | 718 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2006 | 2907 | 0.040 |
Why?
|
| Skin | 2 | 2016 | 4464 | 0.040 |
Why?
|
| Ribonucleases | 1 | 1999 | 276 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2005 | 9574 | 0.040 |
Why?
|
| Saphenous Vein | 2 | 1996 | 517 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4406 | 0.040 |
Why?
|
| Cell Hypoxia | 2 | 2005 | 655 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2008 | 2800 | 0.040 |
Why?
|
| Pyridines | 1 | 2010 | 2859 | 0.040 |
Why?
|
| Tretinoin | 2 | 1992 | 519 | 0.040 |
Why?
|
| Heparitin Sulfate | 2 | 1989 | 224 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13468 | 0.040 |
Why?
|
| Phenols | 1 | 2021 | 514 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 4 | 2008 | 9160 | 0.040 |
Why?
|
| Prostate | 1 | 2006 | 1791 | 0.040 |
Why?
|
| Heterozygote | 1 | 2004 | 2797 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2008 | 2970 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 1734 | 0.040 |
Why?
|
| Aged | 7 | 2022 | 168218 | 0.030 |
Why?
|
| Blood Platelets | 2 | 1978 | 2475 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2004 | 1414 | 0.030 |
Why?
|
| Alleles | 1 | 2008 | 6895 | 0.030 |
Why?
|
| Genotype | 1 | 2011 | 12945 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 2006 | 1227 | 0.030 |
Why?
|
| RNA Interference | 1 | 2005 | 2836 | 0.030 |
Why?
|
| Liver Neoplasms | 3 | 2010 | 4313 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2017 | 2912 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 217 | 0.030 |
Why?
|
| Cell Line, Tumor | 5 | 2014 | 16886 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 2017 | 224 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1996 | 196 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 1751 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2008 | 2312 | 0.030 |
Why?
|
| Xenopus Proteins | 1 | 1998 | 435 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1977 | 344 | 0.030 |
Why?
|
| Neurons | 3 | 2007 | 9416 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2017 | 384 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 1699 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2006 | 3997 | 0.030 |
Why?
|
| Drug Synergism | 3 | 1989 | 1745 | 0.030 |
Why?
|
| Chemokines, CC | 1 | 1996 | 283 | 0.030 |
Why?
|
| United States | 1 | 2023 | 72136 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1998 | 2753 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 3 | 1986 | 953 | 0.030 |
Why?
|
| Venous Insufficiency | 1 | 1996 | 110 | 0.030 |
Why?
|
| Gap Junctions | 1 | 1997 | 230 | 0.030 |
Why?
|
| Cell Membrane | 3 | 1990 | 3680 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2002 | 1271 | 0.030 |
Why?
|
| Drug Stability | 1 | 1995 | 290 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2005 | 1870 | 0.030 |
Why?
|
| Cyclic AMP | 2 | 1990 | 1455 | 0.030 |
Why?
|
| Epiretinal Membrane | 1 | 2015 | 73 | 0.030 |
Why?
|
| Immunoassay | 2 | 1989 | 746 | 0.030 |
Why?
|
| Quinacrine | 1 | 1994 | 24 | 0.030 |
Why?
|
| Keratin-1 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 1988 | 1060 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 1997 | 365 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 1998 | 965 | 0.030 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2016 | 377 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 2017 | 294 | 0.030 |
Why?
|
| Peptides | 2 | 1986 | 4341 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1995 | 278 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1994 | 93 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 1994 | 197 | 0.030 |
Why?
|
| Phospholipase D | 1 | 1994 | 67 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 1996 | 1141 | 0.030 |
Why?
|
| Heparin Lyase | 1 | 1993 | 37 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 1996 | 329 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2015 | 473 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 1992 | 6127 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 1993 | 47 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5864 | 0.030 |
Why?
|
| Mitomycin | 1 | 1994 | 262 | 0.030 |
Why?
|
| Fluoresceins | 1 | 1994 | 234 | 0.030 |
Why?
|
| Thymidine | 2 | 1986 | 299 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1994 | 204 | 0.030 |
Why?
|
| Pheochromocytoma | 4 | 1990 | 328 | 0.030 |
Why?
|
| Staining and Labeling | 4 | 1995 | 1083 | 0.030 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1993 | 56 | 0.030 |
Why?
|
| Thrombospondins | 1 | 1994 | 193 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1996 | 1154 | 0.030 |
Why?
|
| Kinetics | 4 | 1996 | 6371 | 0.030 |
Why?
|
| Retinal Detachment | 2 | 2016 | 427 | 0.030 |
Why?
|
| Introns | 1 | 1996 | 978 | 0.030 |
Why?
|
| Laminin | 3 | 1991 | 405 | 0.030 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1994 | 257 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1996 | 1486 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 3442 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3227 | 0.030 |
Why?
|
| Epoxide Hydrolases | 1 | 2013 | 122 | 0.030 |
Why?
|
| Optic Nerve Injuries | 1 | 1994 | 147 | 0.030 |
Why?
|
| Optic Disk Drusen | 1 | 2013 | 38 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1995 | 906 | 0.030 |
Why?
|
| Propranolol | 1 | 1994 | 489 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1994 | 869 | 0.030 |
Why?
|
| Prostaglandins | 1 | 1993 | 398 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1994 | 361 | 0.030 |
Why?
|
| Mitomycins | 1 | 1992 | 46 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 1994 | 540 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2007 | 3480 | 0.030 |
Why?
|
| Fluorescein Angiography | 2 | 1996 | 1044 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 1125 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 2014 | 2378 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2013 | 226 | 0.020 |
Why?
|
| Breast Neoplasms | 3 | 2012 | 21017 | 0.020 |
Why?
|
| Dextrans | 1 | 1994 | 573 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1610 | 0.020 |
Why?
|
| Plasminogen | 1 | 1991 | 146 | 0.020 |
Why?
|
| Leg | 1 | 1996 | 1087 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2002 | 2560 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 1994 | 255 | 0.020 |
Why?
|
| Chemotaxis | 3 | 1984 | 598 | 0.020 |
Why?
|
| Glutaral | 1 | 1991 | 76 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1992 | 370 | 0.020 |
Why?
|
| Flavonoids | 1 | 1994 | 443 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1020 | 0.020 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1991 | 135 | 0.020 |
Why?
|
| Polyvinyls | 1 | 1991 | 154 | 0.020 |
Why?
|
| Extraembryonic Membranes | 2 | 1981 | 38 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 244 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 1992 | 366 | 0.020 |
Why?
|
| Chromatography | 1 | 1990 | 189 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 2016 | 796 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2014 | 790 | 0.020 |
Why?
|
| Neuropilin-2 | 1 | 2009 | 55 | 0.020 |
Why?
|
| Exons | 1 | 1996 | 2387 | 0.020 |
Why?
|
| Lung | 2 | 2013 | 9985 | 0.020 |
Why?
|
| Visual Pathways | 1 | 1994 | 534 | 0.020 |
Why?
|
| Embryonal Carcinoma Stem Cells | 1 | 1989 | 20 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1984 | 5917 | 0.020 |
Why?
|
| Nitrous Acid | 1 | 1989 | 8 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 242 | 0.020 |
Why?
|
| Bucladesine | 1 | 1989 | 118 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 986 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1994 | 1631 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2011 | 411 | 0.020 |
Why?
|
| Isoelectric Point | 2 | 1986 | 76 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5098 | 0.020 |
Why?
|
| Endotoxins | 1 | 1991 | 521 | 0.020 |
Why?
|
| Adrenal Medulla | 1 | 1988 | 56 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2009 | 237 | 0.020 |
Why?
|
| Tritium | 2 | 1986 | 707 | 0.020 |
Why?
|
| CHO Cells | 2 | 2005 | 1389 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 2105 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1999 | 2108 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2009 | 297 | 0.020 |
Why?
|
| Tissue Distribution | 3 | 1994 | 2262 | 0.020 |
Why?
|
| DNA Probes | 1 | 1989 | 543 | 0.020 |
Why?
|
| Hemangiosarcoma | 1 | 2010 | 216 | 0.020 |
Why?
|
| Lanthanum | 2 | 1978 | 30 | 0.020 |
Why?
|
| Limbus Corneae | 1 | 2009 | 144 | 0.020 |
Why?
|
| Factor Xa | 1 | 1989 | 167 | 0.020 |
Why?
|
| Oncogenes | 1 | 1994 | 1220 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1991 | 961 | 0.020 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1989 | 175 | 0.020 |
Why?
|
| Vitamin A | 1 | 1991 | 613 | 0.020 |
Why?
|
| Cricetinae | 2 | 2005 | 2426 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2008 | 127 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1994 | 1600 | 0.020 |
Why?
|
| Chromium Radioisotopes | 1 | 1987 | 34 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1990 | 1378 | 0.020 |
Why?
|
| Rhodamine 123 | 1 | 1987 | 37 | 0.020 |
Why?
|
| Acridine Orange | 1 | 1987 | 28 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1994 | 793 | 0.020 |
Why?
|
| Isoproterenol | 2 | 1978 | 394 | 0.020 |
Why?
|
| Forecasting | 1 | 1996 | 2923 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 728 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 1996 | 2189 | 0.020 |
Why?
|
| Glutathione | 1 | 2009 | 579 | 0.020 |
Why?
|
| Hybridomas | 1 | 1988 | 442 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1186 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 1989 | 403 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1988 | 361 | 0.020 |
Why?
|
| Chick Embryo | 4 | 1981 | 981 | 0.020 |
Why?
|
| Fibrosis | 1 | 1994 | 2038 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 1989 | 3069 | 0.020 |
Why?
|
| Rhodamines | 1 | 1987 | 178 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 1752 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1988 | 818 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1987 | 389 | 0.020 |
Why?
|
| Cortisone | 1 | 1986 | 87 | 0.020 |
Why?
|
| Protamines | 1 | 1986 | 112 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1990 | 1199 | 0.020 |
Why?
|
| Time Factors | 3 | 2004 | 39872 | 0.020 |
Why?
|
| Myoblasts, Skeletal | 1 | 2005 | 73 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1984 | 306 | 0.020 |
Why?
|
| Norepinephrine | 2 | 1978 | 897 | 0.020 |
Why?
|
| Middle Aged | 8 | 2017 | 219568 | 0.020 |
Why?
|
| Kidney | 2 | 2013 | 7016 | 0.010 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 384 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2011 | 1507 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2016 | 3299 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2472 | 0.010 |
Why?
|
| Epinephrine | 2 | 1978 | 790 | 0.010 |
Why?
|
| Hormones | 1 | 1988 | 869 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 1986 | 559 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1991 | 2204 | 0.010 |
Why?
|
| Autoantigens | 1 | 2008 | 877 | 0.010 |
Why?
|
| Dimerization | 1 | 2005 | 888 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4257 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1986 | 616 | 0.010 |
Why?
|
| Myosins | 1 | 1984 | 405 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 703 | 0.010 |
Why?
|
| Neutrophils | 1 | 2016 | 3765 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3816 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 3432 | 0.010 |
Why?
|
| Epitopes | 1 | 1988 | 2502 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1987 | 1197 | 0.010 |
Why?
|
| Cartilage | 1 | 1986 | 806 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2003 | 562 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 611 | 0.010 |
Why?
|
| Cytokines | 1 | 1996 | 7338 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 2013 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 2858 | 0.010 |
Why?
|
| Zebrafish | 1 | 2012 | 2993 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 1989 | 1346 | 0.010 |
Why?
|
| Hippocampus | 1 | 1993 | 3736 | 0.010 |
Why?
|
| Seizures | 1 | 1993 | 2919 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1996 | 6548 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1985 | 1167 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2005 | 2626 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2006 | 26183 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 2904 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 8143 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1983 | 625 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 3 | 1990 | 733 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1991 | 4215 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 814 | 0.010 |
Why?
|
| Bone Development | 1 | 2002 | 472 | 0.010 |
Why?
|
| Ectoderm | 1 | 1998 | 137 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 2523 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 2002 | 681 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22029 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 1999 | 318 | 0.010 |
Why?
|
| Imipramine | 1 | 1978 | 98 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2002 | 710 | 0.010 |
Why?
|
| Microinjections | 1 | 1998 | 321 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1989 | 2090 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1978 | 451 | 0.010 |
Why?
|
| Skull | 1 | 2002 | 815 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1977 | 327 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1989 | 4540 | 0.010 |
Why?
|
| Chemokine CCL1 | 1 | 1996 | 20 | 0.010 |
Why?
|
| Placenta | 1 | 2006 | 1702 | 0.010 |
Why?
|
| Fetus | 1 | 1984 | 1859 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1978 | 422 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2002 | 1142 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1998 | 795 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 1995 | 44 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1996 | 258 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 20055 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2010 | 3217 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 58683 | 0.010 |
Why?
|
| Pregnancy Proteins | 1 | 1996 | 222 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 2002 | 1091 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 2176 | 0.010 |
Why?
|
| Nerve Crush | 1 | 1994 | 76 | 0.010 |
Why?
|
| DNA Replication | 1 | 1981 | 1410 | 0.010 |
Why?
|
| Monocytes | 1 | 2003 | 2570 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 4312 | 0.010 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1993 | 37 | 0.010 |
Why?
|
| RNA Probes | 1 | 1993 | 111 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1993 | 198 | 0.010 |
Why?
|
| Biological Transport | 1 | 1978 | 2084 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1993 | 158 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1984 | 3072 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1084 | 0.010 |
Why?
|
| Chondrosarcoma | 2 | 1986 | 296 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1992 | 317 | 0.010 |
Why?
|
| Endoderm | 1 | 1992 | 160 | 0.010 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1996 | 914 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 2003 | 10171 | 0.010 |
Why?
|
| Random Allocation | 1 | 1996 | 2385 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1994 | 42062 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1991 | 169 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1986 | 1539 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1743 | 0.010 |
Why?
|
| Fertilization in Vitro | 1 | 1998 | 1292 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 5786 | 0.010 |
Why?
|
| Chorion | 2 | 1980 | 114 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1990 | 202 | 0.010 |
Why?
|
| Aprotinin | 1 | 1989 | 94 | 0.000 |
Why?
|
| Phosphates | 1 | 1992 | 771 | 0.000 |
Why?
|
| Half-Life | 1 | 1989 | 652 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2016 | 80168 | 0.000 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 1986 | 57 | 0.000 |
Why?
|
| Brain | 1 | 1994 | 26947 | 0.000 |
Why?
|
| Reference Values | 1 | 1994 | 4919 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1989 | 1263 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 13245 | 0.000 |
Why?
|
| Peptide Hydrolases | 1 | 1989 | 622 | 0.000 |
Why?
|
| Child | 1 | 1994 | 79818 | 0.000 |
Why?
|
| Sciatic Nerve | 1 | 1989 | 613 | 0.000 |
Why?
|
| Adolescent | 1 | 1994 | 87892 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2005 | 12094 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1986 | 534 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 58808 | 0.000 |
Why?
|
| Pulmonary Circulation | 1 | 1987 | 743 | 0.000 |
Why?
|
| Microbial Collagenase | 1 | 1984 | 112 | 0.000 |
Why?
|
| Chickens | 1 | 1986 | 860 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1983 | 297 | 0.000 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1989 | 952 | 0.000 |
Why?
|
| Protein Kinases | 1 | 1990 | 1610 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1983 | 645 | 0.000 |
Why?
|
| Polyethylene Terephthalates | 1 | 1983 | 115 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1986 | 959 | 0.000 |
Why?
|
| Action Potentials | 1 | 1989 | 1816 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1983 | 940 | 0.000 |
Why?
|
| Allantois | 1 | 1980 | 33 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1993 | 8553 | 0.000 |
Why?
|
| Aqueous Humor | 1 | 1980 | 153 | 0.000 |
Why?
|
| Lenses, Intraocular | 1 | 1981 | 138 | 0.000 |
Why?
|
| Amino Acids | 1 | 1986 | 1713 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1993 | 12262 | 0.000 |
Why?
|
| Milk, Human | 1 | 1983 | 483 | 0.000 |
Why?
|
| Cats | 1 | 1980 | 976 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1990 | 3561 | 0.000 |
Why?
|
| Dogs | 1 | 1983 | 3840 | 0.000 |
Why?
|
| Muscle, Smooth | 1 | 1980 | 924 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1986 | 3609 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1986 | 2292 | 0.000 |
Why?
|
| Melanoma | 1 | 1986 | 5691 | 0.000 |
Why?
|